2026-05-04 – Press Releases – www.prnewswire.com
SINGAPORE, May 4, 2026 /PRNewswire/ — Edwards Lifesciences, the leading global structural heart innovation company, recently announced 10-year results from the COMMENCE aortic trial, reinforcing the long-term durability and sustained performance of its proprietary RESILIA tissue. The…
